Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Leukemia 45Leukemia, Myeloid, Acute 33Congenital Abnormalities 30Leukemia, Lymphocytic, Chronic, B-Cell 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Breast Neoplasms 23Lymphoma, Follicular 21Lymphoma, B-Cell, Marginal Zone 21Lymphoma, Mantle-Cell 19Lymphoma, Large B-Cell, Diffuse 19Lymphoma 19Multiple Myeloma 18Lymphoma, Non-Hodgkin 18Myelodysplastic Syndromes 17Lymphoma, T-Cell, Cutaneous 15Lymphoma, Large-Cell, Immunoblastic 15Burkitt Lymphoma 15Sezary Syndrome 14Myeloproliferative Disorders 14Mycosis Fungoides 14Blast Crisis 14Leukemia, Myelomonocytic, Chronic 13Leukemia, Myeloid, Chronic-Phase 13Leukemia, Myeloid, Accelerated Phase 13Hodgkin Disease 13Waldenstrom Macroglobulinemia 10Primary Myelofibrosis 10Neoplasms, Plasma Cell 10Lymphoma, Large-Cell, Anaplastic 10Leukemia, Megakaryoblastic, Acute 10

Interventions

Cisplatin 35Radiotherapy 21Magnetic Resonance Spectroscopy 19Cetuximab 17Specimen Handling 15pembrolizumab 13Carboplatin 13Radiotherapy, Intensity-Modulated 12Fluorouracil 12Docetaxel 121,2-diaminocyclohexaneplatinum II citrate 10Radiation 9Platinum 9Surgical Procedures, Operative 8Paclitaxel 8Drug Therapy 7Biopsy 7Taxes 5Surveys and Questionnaires 5toripalimab 4X-Rays 4Standard of Care 4Fluorodeoxyglucose F18 4Celecoxib 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3Nutritional Status 3Laser Therapy 3Interviews as Topic 3Immunohistochemistry 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Flow Cytometry × Clear all
NCT00004261 2018-02-22

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

University Health Network, Toronto

Phase 1 Terminated
BreastGenitourinaryGynecologicHead & NeckSarcoma

Breast Carcinoma In Situ, Breast Neoplasms, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡